Min Jung

Min Jung

Auto-generated profile, based on publicly available information

Min Jung

Genentech Inc

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
MJMin Jung
Min Jung
MDMichelle Dourado
Michelle Dourado
JMJames Maksymetz
James Maksymetz
AJAmanda Jacobson
Amanda Jacobson
BLBenjamin I. Laufer
Benjamin I. Laufer
JKJoshua S. Kaminker
Joshua S. Kaminker
Sensory neurons of the dorsal root ganglion (DRG) are critical for maintaining tissue homeostasis by sensing and initiating responses to stimuli. While most preclinical studies of DRGs are conducted in rodents, much less is known about the mechanisms of sensory perception in primates. We generated a transcriptome atlas of mouse, guinea pig, cynomolgus monkey, and human DRGs by implementing a common laboratory workflow and multiple data-integration approaches to generate high-resolution cross-species mappings of sensory neuron subtypes. Using our atlas, we identified conserved core modules highlighting subtype-specific biological processes related to inflammatory response. We also identified divergent expression of key genes involved in DRG function, suggesting species-specific adaptations specifically in nociceptors that likely point to divergent function of nociceptors. Among these, we validated that TAFA4, a member of the druggable genome, was expressed in distinct populations of DRG neurons across species, highlighting species-specific programs that are critical for therapeutic development.

23 February 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ABAlessia Balestrini
Alessia Balestrini
VJVictory Joseph
Victory Joseph
MDMichelle Dourado
Michelle Dourado
RRRebecca M. Reese
Rebecca M. Reese
SSShannon D. Shields
Shannon D. Shields
LRLorena Riol-Blanco
Lorena Riol-Blanco
Despite the development of effective therapies, a substantial proportion of asthmatics continue to have uncontrolled symptoms, airflow limitation, and exacerbations. Transient receptor potential cation channel member A1 (TRPA1) agonists are elevated in human asthmatic airways, and in rodents, TRPA1 is involved in the induction of airway inflammation and hyperreactivity. Here, the discovery and early clinical development of GDC-0334, a highly potent, selective, and orally bioavailable TRPA1 antagonist, is described. GDC-0334 inhibited TRPA1 function on airway smooth muscle and sensory neurons, decreasing edema, dermal blood flow (DBF), cough, and allergic airway inflammation in several preclinical species. In a healthy volunteer Phase 1 study, treatment with GDC-0334 reduced TRPA1 agonist-induced DBF, pain, and itch, demonstrating GDC-0334 target engagement in humans. These data provide therapeutic rationale for evaluating TRPA1 inhibition as a clinical therapy for asthma.

21 July 2023 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
JHJose E Heredia
Jose E Heredia
MJMin Jung
Min Jung
ABAlessia Balestrini
Alessia Balestrini
JDJonas Doerr
Jonas Doerr
APAndres Paler-Martinez
Andres Paler-Martinez
NDNing Ding
Ning Ding
The lung is a barrier tissue with constant exposure to the inhaled environment. Therefore, innate immunity against particulates and pathogens is of critical importance to maintain tissue homeostasis. Although the lung harbors both myelinating and nonmyelinating Schwann cells (NMSCs), NMSCs represent the most abundant Schwann cell (SC) population in the lung. However, their contribution to lung physiology remains largely unknown. In this study, we used the human glial fibrillary acidic protein promoter driving tdTomato expression in mice to identify SCs in the peripheral nervous system and determine their location within the lung. Single-cell transcriptomic analysis revealed the existence of two NMSC populations (NMSC1 and NMSC2) that may participate in pathogen recognition. We demonstrated that these pulmonary SCs produce chemokines and cytokines upon LPS stimulation using in vitro conditions. Furthermore, we challenged mouse lungs with LPS and found that NMSC1 exhibits an enriched proinflammatory response among all SC subtypes. Collectively, these findings define the molecular profiles of lung SCs and suggest a potential role for NMSCs in lung inflammation.

24 June 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
MJMin Jung
Min Jung
MDMichelle Dourado
Michelle Dourado
JMJames Maksymetz
James Maksymetz
AJAmanda Jacobson
Amanda Jacobson
MBMiriam Baca
Miriam Baca
JKJoshua S. Kaminker
Joshua S. Kaminker
Sensory neurons of the dorsal root ganglion (DRG) play a crucial role in maintaining tissue homeostasis by sensing and initiating responses to stimuli. While most preclinical studies of DRGs are conducted in rodents, much less is known about the mechanisms of sensory perception in primates. We generated a transcriptome atlas of mouse, guinea pig, cynomolgus monkey, and human DRGs using a framework that implements a common laboratory workflow and multiple data-integration approaches to generate high-resolution cross-species mappings of sensory neuron subtypes. Using our atlas, we identified conserved core modules highlighting subtype-specific biological processes related to inflammatory response. We also identified divergent expression of key genes involved in DRG function, suggesting species-specific adaptations. Among these, we validated that Tafa4, a member of the druggable genome, was expressed in distinct populations of DRG neurons across species, highlighting species-specific programs that are critical for therapeutic development.

13 July 2022 in Research Square
Verified
Preprint
Open access
PDF file
ZKZia Khan
Zia Khan
MJMin Jung
Min Jung
MCMegan Crow
Megan Crow
RMRajat Mohindra
Rajat Mohindra
VMVidya Maiya
Vidya Maiya
TBTushar Bhangale
Tushar Bhangale
Dose-limiting toxicities significantly impact the benefit/risk profile of many drugs. Whole genome sequencing (WGS) in patients receiving drugs with dose-limiting toxicities can identify therapeutic hypotheses to prevent these toxicities. Peripheral neuropathy (PN) is a common dose-limiting neurological toxicity of chemotherapies with no effective approach for prevention. We conducted a meta-analysis of time-to-PN using WGS data in 4,900 European-ancestry patients receiving chemotherapeutic agents in 14 randomized controlled trials. We identified two low frequency variants associated with PN risk: rs17020773 in intron 13 of GRID2 and rs115575220 downstream of SCG2. Rare coding variant burden analysis identified predicted gain of function variants associated with increased PN risk in the C-terminus of GPR68, a pH-sensitive G-protein coupled receptor (GPCR), that alter arrestin binding motifs. Analysis of snRNA-seq from human dorsal root ganglia indicated that expression of GPR68 was highest in mechano-thermo sensitive nociceptors. Inhibition of GPR68 signaling may provide a strategy to prevent PN in cancer patients.